Serum Brain-derived neurotrophic factor levels in Chinese children with autism spectrum disorders: A pilot study

International Journal of Developmental Neuroscience

Volumn 37, Issue , 2014, Pages 65-68

  Zhang, Qing biao ^a   Jiang, Liang fu ^a   kong, Ling Yu ^b   Lu, Yuan Jun ^a  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b Tumor Hospital of Linyi   (China)

Author keywords

Autism spectrum disorders; Brain derived neurotrophic factor; Chinese; Risk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED GROWTH FACTOR;

ARTICLE; AUTISM; CHILD; CHILDHOOD AUTISM RATING SCALE SCORE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; BLOOD; CHINA; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; STATISTICS;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; MALE; PILOT PROJECTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84904332149     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.06.013     Document Type: Article

References (28)

1. Abdallah M.W., Mortensen E.L., Greaves Lord K., Larsen N., Bonefeld Jørgensen E.C., Nørgaard Pedersen B., et al. Neonatal levels of neurotrophic factors and risk of autism spectrum disorders. Acta Psychiatr. Scand. 2013, 128(1):61-69.
2. Al-Ayadhi L.Y. Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochem. Res. 2012, 37(2):394-400.
3. Bashir S., AL-Ayadhi L. Role of serum levels of neurotensin in children with autism spectrum disorder. Neurol. Psychiatry Brain Res. 2013, 19(2):59-63.
4. Bozzola M., Ntodou-Thome A., Bona G., Autelli M., Magnani M.L., Radetti G., Schimpff R.M. Possible role of plasma neurotensin on growth hormone regulation in neonates. J. Pediatr. Endocrinol. Metabol. 1998, 11(5):607-614.
5. Ciammola A., Sassone J., Cannella M., Calza S., Poletti B., Frati L., et al. Low brain, derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2007, 144(4):574-577.
6. Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M., et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 2006, 59(4):354-363.
7. Croen L.A., Goines P., Braunschweig D., Yolken R., Yoshida C.K., Grether J.K., et al. Brain, derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) study. Autism Res. 2008, 1(2):130-137.
8. Donelan J., Boucher W., Papadopoulou N., Lytinas M., Papaliodis D., Theoharides T.C. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7759-7764.
9. Enstrom A., Onore C., Tarver A., Hertz-Picciotto I., Hansen R., Croen L., et al. Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism. Am. J. Biochem. Biotechnol. 2008, 4(2):121-129.
10. Freitag C.M., Staal W., Klauck S.M., Duketis E., Waltes R. Genetics of autistic disorders: review and clinical implications. Eur. Child Adolesc. Psychiatry 2010, 19(3):169-178.
11. Gong Z.L., Luo C.M., Wang L., Shen L., Wei F., Tong R.J., Liu Y. Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. NeuroReport 2014, 25(1):23-27.
12. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatry 2011, 16(9):960-972.
13. Harada M., Taki M.M., Nose A., Kubo H., Mori K., Nishitani H., Matsuda T. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J. Autism Dev. Disord. 2011, 41(4):447-454.
14. Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., et al. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2006, 30(8):1529-1531.
15. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 2005, 57(9):1068-1072.
16. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 2002, 328(3):261-264.
17. Katoh-Semba R., Wakako R., Komori T., Shigemi H., Miyazaki N., Ito H., et al. Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. Int. J. Dev. Neurosci. 2007, 25(6):367-372.
18. Mansour M., Mohamed A., Azam H., Henedy M. Brain derived neurotrophic factor in autism. Curr. Psychiatry 2010, 17(1):23-29.
19. Miyazaki K., Narita N., Sakuta R., Miyahara T., Naruse H., Okado N., Narita M. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev. 2004, 26(5):292-295.
20. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 2001, 49(5):597-606.
21. Nelson P.G., Kuddo T., Song E.Y., Dambrosia J.M., Kohler S., Satyanarayana G., et al. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Dev. Neurosci. 2006, 24(1):73-80.
22. Nickl-Jockschat T., Michel T.M. The role of neurotrophic factors in autism. Mol. Psychiatry 2011, 16(5):478-490.
23. Nishimura K., Nakamura K., Anitha A., Yamada K., Tsujii M., Iwayama Y., et al. Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism. Biochem. Biophys. Res. Commun. 2007, 356(1):200-206.
24. Sajdel-Sulkowska E.M., Xu M., McGinnis W., Koibuchi N. Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 2011, 10(1):43-48.
25. Schopler E., Reichler R.J., DeVellis R.F., Daly K. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J. Autism Dev. Disord. 1980, 10(1):91-103.
26. Tsai S.J. Is autism caused by early hyperactivity of brain-derived neurotrophic factor?. Med. Hypotheses 2005, 65(1):79-82.
27. Tu W.J., Yin C.H., Guo Y.Q., Li S.O., Chen H., Zhang Y., et al. Serum homocysteine concentrations in Chinese children with autism. Clin. Chem. Lab. Med. 2013, 51(2):e19-e22.
28. Wingate M., Kirby R.S., Pettygrove S., Cunniff C., Schulz E., Ghosh T., et al. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill. Summ. 2014, 63(2):1-21.